Benefits
Superior antioxidant effect vs isolated vitamin C
In Inoue 2008, after 7 days, urinary 8-hydroxy-deoxyguanosine (oxidative DNA damage marker, p<0.05) and total reactive oxygen species (p<0.01) decreased significantly in the camu-camu group but NOT in the equivalent isolated vitamin C group. This suggests camu-camu's polyphenol matrix contributes effects beyond ascorbic acid alone.
Anti-inflammatory effect
Inoue 2008 also demonstrated reductions in inflammatory markers (high-sensitivity CRP and IL-6) in the camu-camu group that were not seen with matched isolated vitamin C dosing. Effect attributed to the synergy of vitamin C with camu-camu's anthocyanins, ellagic acid, and other phenolic compounds.
High natural vitamin C density
Camu-camu contains ~2,000-3,000 mg vitamin C per 100 g of fresh fruit — among the highest known natural sources, surpassed only by some species like Acerola. Provides natural co-factor matrix (bioflavonoids, anthocyanins) thought to support vitamin C absorption and stability.
Polyphenol-mediated antioxidant capacity
Beyond vitamin C, camu-camu provides anthocyanins (especially cyanidin 3-glucoside), ellagic acid, ellagitannins, and rutin. The systematic review noted this combined antioxidant matrix as the basis for camu-camu's benefits exceeding what isolated vitamin C provides.
Mechanism of action
Vitamin C-mediated free radical neutralization
Ascorbic acid donates electrons to neutralize reactive oxygen species and regenerate other antioxidants (especially vitamin E). High vitamin C bioavailability supports tissue saturation, immune cell function, and collagen synthesis.
Anthocyanin and ellagitannin signaling
Cyanidin 3-glucoside and ellagic acid modulate NF-κB and Nrf2 antioxidant response pathways. These polyphenols also have direct radical-scavenging activity that complements vitamin C's water-soluble compartment activity.
Vitamin C transporter upregulation
Takino 2020 (Caco-2 intestinal cell model — closely related Acerola) demonstrated that fruit phytochemicals can upregulate SVCT1 transporter expression, enhancing intracellular vitamin C uptake. Similar mechanism may apply to camu-camu's matrix bioavailability advantage.
Clinical trials
Randomized comparator trial (Inoue, Komoda, Uchida, Node 2008, J Cardiol 52(2):127-32).
20 male smoking volunteers (chosen as a model of accelerated oxidative stress). Randomized to 70 mL of 100% camu-camu juice (1050 mg vitamin C, n=10) OR 1050 mg vitamin C tablets (n=10) daily for 7 days.
After 7 days, camu-camu group showed significant reductions in urinary 8-hydroxy-deoxyguonosine (p<0.05) and total reactive oxygen species (p<0.01) plus reductions in hs-CRP and IL-6 inflammatory markers. The equivalent dose of isolated vitamin C did NOT produce these effects. Authors concluded camu-camu has antioxidant and anti-inflammatory properties beyond what its vitamin C content alone explains.
Systematic review (Langley, Pergolizzi, Taylor, Ridgway 2015, J Altern Complement Med 21(1):8-14).
Aggregated all human and preclinical studies on camu-camu antioxidant capacity available to that date.
Confirmed camu-camu's role as a mediator for inflammation and antioxidant stress. Authors emphasized that the unique vitamin C content combined with flavonoids and anthocyanins represents the basis for benefits, and called for additional well-controlled human trials to establish dose-response and long-term outcomes.
Comprehensive review of camu-camu antioxidant compounds and mechanisms (Avila-Sosa, Montero-Rodriguez, Aguilar-Alonso, Vera-Lopez, Lazcano-Hernandez, Morales-Medina, Navarro-Cruz 2019, Oxid Med Cell Longev 8204129).
Aggregated chemical, in vitro, animal, and limited human data through 2019.
Confirmed camu-camu contains more vitamin C than any other studied fruit (~2-3 g/100 g pulp), with the dominant phenolic compounds including ellagitannins, ellagic acid, anthocyanins, and rutin. Authors concluded the antioxidant capacity and anti-inflammatory effects make camu-camu a promising functional food, while flagging that human trials remain limited compared to the strong preclinical case.